META:PHI is excited to be able to shine a light into the important matters that practitioners across Ontario face when caring for patients in RAAM clinics and other settings.
We hope that in sharing this information among our healthcare community, we can provide more sustainable direction and support for our patients as they move along their path to recovery.
We will discuss these topics with a lens into the implications these issues may have on direct practice and patient care.
We also welcome any suggestions for topics or issues related to substance use and treatment.
Nov 2, 2018
With the recent legalization of cannabis in Canada, the question of its impact on youth is very much uncertain. According to the 2015 Canadian Tobacco, Alcohol and Drugs Survey, the rate of cannabis use…
Tagged cannabis, implications for practice, youth
Sep 28, 2018
Currently, Canada has among the highest rates of cannabis use in the world. It remains unclear how the upcoming legalization of cannabis will impact the current rates of use, but clinicians will likely…
Tagged cannabis, implications for practice, RAAM
Aug 30, 2018
As of June 29, 2018, acamprosate and naltrexone can be prescribed under Limited Use Status in Ontario. Prescribers will no longer be required to obtain approval through the Exceptional Access Program.…
Tagged alcohol use disorder, implications for practice, MOHLTC, pharmacotherapy
Aug 16, 2018
Recently, the Ontario Ministry of Transportation (MTO) issued new amendments to the Highway Traffic Act (HTA) that include both mandatory and discretionary reporting guidelines for certain healthcare professionals.…
Tagged implications for practice, MTO, reporting